Legal & General Group
INSY

Legal & General Group’s Insys Therapeutics, Inc. INSY Stock Holding History

Legal & General Group’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-3,801
Closed -$18K – 3504
2019
Q1 		$18K Hold
3,801
– – ﹤0.01% 3137
2018
Q4 		$13K Hold
3,801
– – ﹤0.01% 3224
2018
Q3 		$38K Sell
3,801
-1,727
-31% -$13.8K ﹤0.01% 2916
2018
Q2 		$41K Hold
5,528
– – ﹤0.01% 2854
2018
Q1 		$33K Sell
5,528
-3,820
-41% -$31.5K ﹤0.01% 2955
2017
Q4 		$87K Buy
9,348
+1,478
+19% +$9.67K ﹤0.01% 2654
2017
Q3 		$70K Hold
7,870
– – ﹤0.01% 2807
2017
Q2 		$100K Hold
7,870
– – ﹤0.01% 2608
2017
Q1 		$84K Sell
7,870
-95
-1% -$1.01K ﹤0.01% 2645
2016
Q4 		$73K Buy
7,965
+2,088
+36% +$23.6K ﹤0.01% 2738
2016
Q3 		$69K Sell
5,877
-370
-6% -$5.62K ﹤0.01% 2378
2016
Q2 		$78K Hold
6,247
– – ﹤0.01% 2241
2016
Q1 		$100K Buy
6,247
+876
+16% +$16.6K ﹤0.01% 2041
2015
Q4 		$154K Hold
5,371
– – ﹤0.01% 1862
2015
Q3 		$151K Buy
5,371
+1,727
+47% +$63.6K ﹤0.01% 1833
2015
Q2 		$130K Hold
3,644
– – ﹤0.01% 1949
2015
Q1 		$106K Hold
3,644
– – ﹤0.01% 2003
2014
Q4 		$79K Hold
3,644
– – ﹤0.01% 2146
2014
Q3 		$71K Buy
+3,644
New +$57.2K ﹤0.01% 2160

Other funds holding INSY

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Legal & General Group's INSY Position: Q2 2019 in Review

Legal & General Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 3,801 shares — an estimated $18K sold.

Legal & General Group first reported a position in INSY in Q3 2014 and held it in 19 quarters. The position peaked at $154K in Q4 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

  • Legal & General Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Legal & General Group sold 3,801 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $18K.
  • Legal & General Group first reported a position in Insys Therapeutics, Inc. in Q3 2014 and held it in 19 quarters.
  • Legal & General Group's Insys Therapeutics, Inc. position peaked at $154K in Q4 2015.
  • 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Legal & General Group's 13F filing for Q2 2019, filed 14 Aug 2019.